Skip to main content
Veterinary Medicines

ADVOCIN 180, 180 MG/ML, SOLUTION FOR INJECTION FOR CATTLE

Authorised
  • Danofloxacin mesilate

Product identification

Medicine name:
ADVOCIN 180, 180 MG/ML, SOLUTION FOR INJECTION FOR CATTLE
ADVOCINE 180, 180 MG/ML, SOLUTION INJECTABLE POUR BOVINS
Active substance:
  • Danofloxacin mesilate
Target species:
  • Cattle
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Danofloxacin mesilate
    228.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        4
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA92
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/8836921 1/2001
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0126/001
Concerned member states:
  • Belgium
  • Germany
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/11/2023

Combined File of all Documents

English (PDF)
Published on: 19/02/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 29/06/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."